Print
Health Care

Alcami Buys Massachusetts Company

By Staff Reports, posted Dec 16, 2021
Alcami Corp. announced that it has acquired another company that serves the pharmaceutical industry. (File photo)

Alcami Corp., a Wilmington-based company, announced this week it has acquired another pharma firm.

Itself a pharmaceutical and biotech contract development and manufacturing organization (CDMO), Alcami bought Masy Systems Inc., a provider of cGMP Biostorage and pharma support services, for an undisclosed amount, according to a news release. 

The abbreviation "cGMP" in the pharmaceutical industry stands for "current good manufacturing practices."

"The acquisition of Masy adds complementary service offerings and further reinforces Alcami's ambitious growth and expansion initiatives," said Patrick Walsh, chairman and CEO of Alcami, in the release.

Alcami company officials announced in January that it was investing $2 million in its Wilmington site, 2320 Scientific Park Drive, to expand its oral solid development and manufacturing capabilities. The firm has about 400 employees in Wilmington.

Masy was founded in 1984 by entrepreneurs Laurie and John Masiello and operates three cGMP Biostorage facilities in Massachusetts, all within an hour of Boston and Cambridge, with a fourth facility set to open in early 2022, the release stated.

"The company offers secure and tightly controlled cGMP temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds and medical devices," according to the release.

The company's pharma support services include equipment calibration, large-scale validation and qualification projects, SenseAnywhere monitoring solutions and validation and calibration equipment sales and rentals, the release stated.

Masy's additional pharma support service operations are located in California, Pennsylvania, New Jersey and North Carolina.

"We built an amazing company at Masy and are thrilled to partner with the Alcami team, as our combined resources and capabilities will result in enhanced support for our customers," Lauri Masiello stated in the release.

Benefits for Masy clients include immediate access to Alcami's service offerings ranging from analytical development and testing to full drug product development and manufacturing, both sterile fill-finish and oral solid dose, according to the release.

The release also said, "Similarly, Alcami's extensive client base will have access to Masy's available and growing cGMP Biostorage capacity and extensive pharma support services."

Ico insights

INSIGHTS

SPONSORS' CONTENT
Mc2 56882

Landing Whales Requires A Larger Ocean With More Food

Scott Byers - Majestic Kitchen & Bath Creations
Atromitos micheallegady headshot

Small Business Owner: Know Thy Finances

Michealle Gady - Atromitos
Brookeskipper saltair headshot2

How To Know If It’s Time For A New HVAC System

Brooke Skipper - Salt Air

Trending News

National Retailer Coming To Former Earth Fare Space

Cece Nunn - Jan 24, 2022

Carolina Beach Fishing Pier, Tiki Bar Under Contract 

Johanna F. Still - Jan 24, 2022

In The Current Issue

Info Junkie: Kimberly Lupo

The founder and CEO of Portrett Pharmaceuticals, Kimberly Lupo, shares her top tech and info picks....


Downtown In Demand

While suitable live, work and play space – and places to create more – are in high demand in downtown Wilmington, the inventory is low. But...


Meet The Region's On-call Utility Engineer

One man and one team are behind nearly every major public water and sewer infrastructure project in the Cape Fear region....

Book On Business

The 2021 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

Trying to Grow a Business?
2020 Health Care Heroes
2020 WilmingtonBiz 100